Literature DB >> 9951513

Interstitial brachytherapy in carcinoma of the penis.

A J Chaudhary1, S Ghosh, R L Bhalavat, J N Kulkarni, B V Sequeira.   

Abstract

AIM: Keeping in line with the increasing emphasis on organ preservation, we at the Tata Memorial Hospital have evaluated the role of Ir-192 interstitial implant as regards local control, functional and cosmetic outcome in early as well as locally recurrent carcinoma of the distal penis. PATIENTS AND METHODS: From October 1988 to December 1996, 23 patients with histopathologically proven cancer of the penis were treated with radical radiation therapy using Ir-192 temporary interstitial implant. Our patients were in the age group of 20 to 60 years. The primary lesions were T1 in 7, T2 in 7 and recurrent in 9 patients. Only 7 patients had palpable groin nodes at presentation, all of which were pathologically negative. The median dose of implant was 50 Gy (range 40 to 60 Gy), using the LDR afterloading system and the Paris system of implant rules for dosimetry. Follow-up ranged from 4 to 117 months (median 24 months).
RESULTS: At last follow-up 18 of the 23 patients remained locally controlled with implant alone. Three patients failed only locally, 2 locoregionally and 1 only at the groin. Of the 5 patients who failed locally, 4 were successfully salvaged with partial penectomy and remained controlled when last seen. Local control with implant alone at 8 years was 70% by life table analysis. The patients had excellent functional and cosmetic outcome. We did not record any case of skin or soft-tissue necrosis. Only 2 patients developed meatal stenosis, both of which were treated endoscopically.
CONCLUSION: Our results lead us to interpret that interstitial brachytherapy with Ir-192 offers excellent local control rates with preservation of organ and function. Penectomy can be reserved as a means for effective salvage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9951513     DOI: 10.1007/BF02743456

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

1.  Sapphire probe laser surgery for localized carcinoma of the penis.

Authors:  T A Boon
Journal:  Eur J Surg Oncol       Date:  1988-04       Impact factor: 4.424

Review 2.  Penile amputations for the management of primary carcinoma of the penis.

Authors:  S Das
Journal:  Urol Clin North Am       Date:  1992-05       Impact factor: 2.241

3.  [Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations].

Authors:  L Piva; N Nicolai; A Di Palo; A Milani; M Merson; R Salvioni; S Stagni; D Vecchio; F Zanoni; S Ferri; G Pizzocaro
Journal:  Arch Ital Urol Androl       Date:  1996-06

4.  The place of radiation therapy in the treatment of carcinoma of the distal end of the penis.

Authors:  K Haile; L Delclos
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

5.  Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients).

Authors:  R Rozan; E Albuisson; B Giraud; D Donnarieix; M Delannes; J Pigneux; S Hoffstetter; A Gerbaulet; P Chinet-Charrot; A Goupil
Journal:  Radiother Oncol       Date:  1995-08       Impact factor: 6.280

6.  The results of primary radiation therapy in the management of squamous cell carcinoma of the penis.

Authors:  M McLean; A M Akl; P Warde; R Bissett; T Panzarella; M Gospodarowicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

7.  Iridium-192 interstitial therapy for squamous cell carcinoma of the penis.

Authors:  M Delannes; B Malavaud; J Douchez; J Bonnet; N J Daly
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

8.  Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970-1979).

Authors:  J J Mazeron; D Langlois; P A Lobo; J A Huart; E Calitchi; A Lusinchi; M Raynal; J P Le Bourgeois; C C Abbou; B Pierquin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-10       Impact factor: 7.038

  8 in total
  9 in total

1.  Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.

Authors:  Johannes Seibold; Vratislav Strnad; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-06-09       Impact factor: 3.621

Review 2.  What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes.

Authors:  Vasileios I Sakalis; Riccardo Campi; Lenka Barreto; Herney Garcia Perdomo; Isabella Greco; Łukasz Zapala; Mithun Kailavasan; Tiago Antunes-Lopes; Jack David Marcus; Kenneth Manzie; John Osborne; Benjamin Ayres; Luc M F Moonen; Andrea Necchi; Juanita Crook; Pedro Oliveira; Lance C Pagliaro; Chris Protzel; Arie S Parnham; Maarten Albersen; Curtis A Pettaway; Philippe E Spiess; Scott T Tagawa; R Bryan Rumble; Oscar R Brouwer
Journal:  Eur Urol Open Sci       Date:  2022-05-02

3.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

Review 4.  Contemporary role of radiotherapy in the management of penile cancer.

Authors:  Martin Arthur Korzeniowski; Juanita Mary Crook
Journal:  Transl Androl Urol       Date:  2017-10

5.  High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis.

Authors:  Nicolas Martz; Yohan Bodokh; Mathieu Gautier; Brice Thamphya; Renaud Schiappa; Daniel Lam Cham Kee; Daniel Chevallier; Arthur Hannoun; Marie-Eve Chand; Jean-Michel Hannoun-Levi
Journal:  Clin Transl Radiat Oncol       Date:  2021-01-17

6.  Penile cancer brachytherapy HDR mould technique used at the Holycross Cancer Center.

Authors:  Robert Matys; Iwona Kubicka-Mendak; Jarosław Lyczek; Piotr Pawłowski; Iwona Stawiarska; Joanna Miedzinska; Paweł Banatkiewicz; Aldona Laskawska-Wiatr; Justyna Wittych
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

7.  High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.

Authors:  Yohann Rouscoff; Alexander Tuan Falk; Matthieu Durand; Jocelyn Gal; Marie-Eve Chand; Mathieu Gautier; Alexandre Marsaud; Daniel Chevallier; Jean Amiel; Jean-Michel Hannoun-Levi
Journal:  Radiat Oncol       Date:  2014-06-19       Impact factor: 3.481

8.  Testicular shielding in penile brachytherapy.

Authors:  Arpita Bindal; Umesh Mahantshetty; Chandrashekhar M Tambe; Yogesh Ghadi; Vedang Murthy; Shyam Kishore Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2015-12-16

9.  Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis.

Authors:  Xiheng Hu; Jianghai Huang; Sailan Wen; Jun Fu; Minfeng Chen
Journal:  Oncotarget       Date:  2017-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.